Chris Rhodes has over 40 years experience in diabetes/obesity/metabolic research, mostly focused molecular mechanisms in the pathogenesis of diabetes, obesity and related metabolic disease. He trained at the University of London obtaining his PhD in Biochemistry, followed by postdoctoral fellowships at the Joslin Diabetes Center and the University of Cambridge. He then had faculty positions at the Joslin Diabetes Center/Harvard Medical School, the University of Texas Southwestern Medical School at Dallas, the Pacific Northwest Research Institute/University of Washington in Seattle, then at the University of Chicago as Research Director of the Kovler Diabetes Center and Chair of the Biomedical Sciences Cluster graduate programs. In 2015, he joined AstraZenca Vice President for Cardiovascular, Renal and Metabolic Disease (CVRM) Research & Development at MedImmune and is now Chief Scientist in CVRM and Chair of AstraZeneca Global Postdoctoral Program. He retains a Professorship Emeritus at the University of Chicago.